1. Sweden Stocks

  2. •

    Finance

  3. •

    Investment banks/Brokers
Vastra Hamnen Corporate Finance AB

Vastra Hamnen Corporate Finance AB

SSTO:VH
14.30
SEK
-0.10
(-0.69%)
-1.27EPS
14.05MMarket Cap
Vastra Hamnen Corporate Finance AB
STO:VH
(Nasdaq Stockholm)

Recent

price

14.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
SEK
- -
35.27
11.32
11.77
13.45
7.86
8.46
Revenue per Share
9.65
17.87
3.15
2.99
1.68
-3.26
-1.27
Basic EPS, GAAP
- -
18.83
-8.94
3.85
-0.59
-5.06
-1.25
Free Cash Flow per Basic Share
- -
11.19
14.92
2.8
2.8
1.4
- -
Dividend per Share
17.69
24.37
12.66
12.85
11.73
7.07
14.64
Book Value per Share
17.69
24.37
12.66
12.85
11.73
7.07
14.64
Tangible Book Value per Share
1
1
1
1
1
1
1
Basic Weighted Avg Shares
- -
38
12
13
14
8
9
Sales/Revenue/Turnover
- -
56.15
35.16
28.86
13.47
-53.41
-31.89
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
10
19
3
3
2
-3
-1
Net Income, GAAP
21.6
20.94
22.21
22.02
21.77
- -
- -
Effective Tax Rate (%)
- -
50.66
27.87
25.38
12.45
-41.42
-14.96
Profit Margin (%)
20
26
13
12
10
5
8
Working Capital
- -
- -
- -
- -
- -
- -
- -
LT Debt
19
26
14
14
13
8
16
Total Equity
- -
68.36
15.03
21.91
12.78
- -
- -
Return on Invested Capital (%)
- -
84.96
17.05
23.51
13.65
- -
- -
Return on Capital (%)
- -
84.96
17.04
23.43
13.63
-34.63
-10.92
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
33
25
14

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
8
5
11
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
3
3
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-11.44%
-39.68%
Free Cash Flow
- -
- -
764.01%
Net Income, GAAP
- -
-68.15%
-294.32%
Sales/Revenue/Turnover
- -
- -
-41.57%
Total Cash Common Dividend
- -
- -
-50%

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3
3
1
8
14
2025
1
4
2
1
8
2026
1
5
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.18
-0.48
-1.43
3.41
1.68
2025
-2.42
0.75
-0.79
-0.78
-3.26
2026
-1.18
1.45
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
2.8
- -
- -
2.8
2025
- -
1.44
- -
- -
1.4
2026
- -
- -
- -
- -
- -
Similar Companies
Robinhood Markets, Inc. (NASDAQ:HOOD)
Coinbase Global, Inc. (NASDAQ:COIN)
BSE Ltd. (NSE:BSE)
Goldman Sachs Group, Inc. (The) (NYSE:GS)
Multi Commodity Exchange of India Limited (NSE:MCX)
National Stock Exchange of India Limited (BSE:NSE)
Business
Västra Hamnen Corporate Finance AB (publ) Västra Hamnen Corporate Finance AB (publ) is an independent securities company that provides corporate finance advisory services to small and medium-sized companies in Sweden and Denmark. The company offers corporate finance solutions including stock exchange transactions such as listings, directed issues, rights issues of shares, convertibles and warrants; private capital raising through financing rounds leveraging a network of investors; and corporate transactions encompassing company sales, mergers and acquisitions; alongside certified adviser services for regulatory compliance and guidance; and Market Focus, a stock analysis service for small and medium-sized listed companies to enhance investor awareness and share turnover. Founded in 2004 and headquartered in Malmö, Sweden, at Jungmansgatan 12, it operates under the supervision of Finansinspektionen with approximately 10 employees targeting growth-oriented businesses in the financial services sector. Recent activities include providing a fairness opinion dated 18 November 2025 for the statutory merger between Flerie Invest AB and Lipum AB (publ), where Lipum is absorbed by Flerie with operations contributed to a new subsidiary, conditional on shareholder approvals and loan set-offs; ongoing Market Focus coverage updates such as analyses on ProstaLund, Bioextrax, aXichem and Xintela in 2025; and a history of facilitating significant transactions like a SEK 250 million rights issue and undisclosed M&A deals.